SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-057420
Filing Date
2017-09-15
Accepted
2017-09-15 16:35:24
Documents
8
Period of Report
2017-09-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-22045_18k.htm 8-K 43551
2 EX-1.1 a17-22045_1ex1d1.htm EX-1.1 224230
3 EX-5.1 a17-22045_1ex5d1.htm EX-5.1 9023
4 EX-99.1 a17-22045_1ex99d1.htm EX-99.1 10060
5 EX-99.2 a17-22045_1ex99d2.htm EX-99.2 10753
6 GRAPHIC g220451moi001.jpg GRAPHIC 8760
7 GRAPHIC g220451kgi001.gif GRAPHIC 7591
8 GRAPHIC g220451mmi001.jpg GRAPHIC 4894
  Complete submission text file 0001104659-17-057420.txt   328421
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-16633 | Film No.: 171088311
SIC: 2834 Pharmaceutical Preparations